title: Development of intrastriatal striatal grafts and their afferent innervation from the host.
abstract: The morphological maturation of cell suspension grafts of fetal striatal tissue (obtained from 14-15-day-old rat fetuses) was followed from two days to eight weeks after implantation into intact and ibotenic acid-lesioned striata of adult rats. The development of host afferent innervation of the grafts from the substantia nigra (tyrosine hydroxylase immunoreactive), mesencephalic raphe (serotonin immunoreactive), and the frontal cortex (anterogradely labelled with Phaseolus vulgaris leucoagglutinin) were revealed by immunohistochemistry. During the first weeks post-grafting, the striatal implants consisted of a mixture of mature- and immature-looking cell clusters. Grafts implanted into ibotenic acid-lesioned striatum grew rapidly (about five-fold) in volume over the first week. The areas of immature (probably proliferating) cells gradually disappeared, and by six to eight weeks the grafts had a fully mature appearance with patches of neurons which stained densely for DARPP-32 (i.e. were striatum-like) embedded within areas of essentially DARPP-32-negative (i.e. non-striatum-like) tissue. Peripheral clusters of grafted cells gradually intermingled with nearby areas of the surrounding lesioned host, and already by two to four days after implantation, coarse and densely immunoreactive host fibres from the substantia nigra, mesencephalic raphe and frontal cortex were present within the grafts. By four to five days the first DARPP-32-immunoreactive neurons appeared in patches within the mature portions of the grafts, and one to two days later the tyrosine hydroxylase-positive fibres began to sprout thin axons selectively within the DARPP-32-positive patches. Similarly, the serotonergic and cortical fibres in the grafts increased in number over the next two weeks, but they showed no preference for the DARPP-32-positive regions. Rich terminal networks were established by two to three weeks post-grafting, and by six to eight weeks the nigral, raphe and cortical afferents had reached terminal densities similar to those seen previously in long-term surviving grafts. Grafts implanted into dopamine-denervated hosts showed a normal morphological maturation of both DARPP-32-positive and -negative areas, although no tyrosine hydroxylase-positive innervation appeared within the grafts. Grafts implanted into non-lesioned striata did not grow beyond their initial size. The implanted cells showed less intermingling with the surrounding host striatum, thus resulting in sharply delineated graft-host borders. DARPP-32-positive patches developed, but they were smaller in size and generally present only in the most peripheral graft portions.(ABSTRACT TRUNCATED AT 400 WORDS)
authors.affiliation: Department of Medical Cell Research, University of Lund, Sweden.
authors.forename: J L
authors.initials: JL
authors.lastname: Labandeira-Garcia
authors.forename: K
authors.initials: K
authors.lastname: Wictorin
authors.forename: E T
authors.initials: ET
authors.lastname: Cunningham
authors.forename: A
authors.initials: A
authors.lastname: Björklund
mesh_terms: D000818:Animals; D016380:Brain Tissue Transplantation / Q000502:physiology*; D002531:Cerebellum / Q000166:cytology / Q000201:enzymology; D002540:Cerebral Cortex / Q000033:anatomy & histology / Q000201:enzymology; D003342:Corpus Striatum / Q000166:cytology / Q000254:growth & development*; D004298:Dopamine / Q000502:physiology; D051937:Dopamine and cAMP-Regulated Phosphoprotein 32; D005260:Female; D016332:Fetal Tissue Transplantation / Q000502:physiology; D007150:Immunohistochemistry; D009419:Nerve Tissue Proteins / Q000032:analysis / Q000737:chemistry / Q000276:immunology; D009475:Neurons, Afferent / Q000166:cytology / Q000201:enzymology / Q000502:physiology*; D010750:Phosphoproteins; D010835:Phytohemagglutinins; D011247:Pregnancy; D011903:Raphe Nuclei / Q000033:anatomy & histology / Q000201:enzymology; D051381:Rats; D011919:Rats, Inbred Strains; D013194:Staining and Labeling; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism
chemical_list: D051937:Dopamine and cAMP-Regulated Phosphoprotein 32; D009419:Nerve Tissue Proteins; D010750:Phosphoproteins; D010835:Phytohemagglutinins; C100156:leukoagglutinins, plants; D014446:Tyrosine 3-Monooxygenase; D004298:Dopamine